Metraipolis › archive › dc_9db4a2a2d95c

Identification of a Proteomic Signature for Predicting Immunotherapy Response in Patients With Metastatic Non-Small Cell Lung Cancer — Europe PMC PMID:39216661

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39216661
DOI
10.1016/j.mcpro.2024.100834
License (as archived)
solo-consultazione
Archived
2026-10-31T10:01:59.603Z
SHA-256 of the archived text
ce17fb6eeb0ec046ced65a807fee4a8a3557c39fb557e203e144f6320b6bf7d3
Stable URL of this page
https://metraipolis.com/documento/dc_9db4a2a2d95c

How to cite

Identification of a Proteomic Signature for Predicting Immunotherapy Response in Patients With Metastatic Non-Small Cell Lung Cancer — Europe PMC PMID:39216661 — Europe PMC (en), https://europepmc.org/article/MED/39216661 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9db4a2a2d95c (Metraipolis archive dc_9db4a2a2d95c, sha256 ce17fb6eeb0ec046ced65a807fee4a8a3557c39fb557e203e144f6320b6bf7d3)
BibTeX
@misc{dc9db4a2a2d95c,
  title = {Identification of a Proteomic Signature for Predicting Immunotherapy Response in Patients With Metastatic Non-Small Cell Lung Cancer — Europe PMC PMID:39216661},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39216661},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9db4a2a2d95c; sha256 ce17fb6eeb0ec046ced65a807fee4a8a3557c39fb557e203e144f6320b6bf7d3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39216661. Agents can read the archived copy with the MCP tool read_document.